Validation of Korean Version of the London Chest Activity of Daily Living Scale in Patients With Chronic Obstructive Pulmonary Disease.
10.5535/arm.2018.42.2.329
- Author:
Jun Tak CHOI
1
;
Jeong Hwan SEO
;
Myoung Hwan KO
;
Sung Hee PARK
;
Gi Wook KIM
;
Yu Hui WON
Author Information
1. Department of Physical Medicine and Rehabilitation, Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, Korea. wonyh@jbnu.ac.kr
- Publication Type:Original Article
- Keywords:
Validation;
Chronic obstructive pulmonary disease;
Activities of daily living;
Dyspnea
- MeSH:
Activities of Daily Living;
Dyspnea;
Forced Expiratory Volume;
Humans;
Pulmonary Disease, Chronic Obstructive*;
Reproducibility of Results;
Respiratory Function Tests;
Thorax*;
Vital Capacity
- From:Annals of Rehabilitation Medicine
2018;42(2):329-335
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: To translate the English version of the London Chest Activity of Daily Living scale (LCADL) into a Korean version and to determine the reliability and validity of the Korean version in patients with chronic obstructive pulmonary disease (COPD). METHODS: The English version of LCADL was translated into Korean and back-translated into English. Subsequently, the back-translated version was reviewed and compared with the original, and thus the final K-LCADL was obtained. To evaluate the validation of the K-LCADL, patients simultaneously completed a pulmonary function test, a 6-Minute Walk Test (6MWT), and questionnaires, including the modified Medical Research Council (mMRC) dyspnea scale, the Korean version of the St. George's Respiratory Questionnaire (K-SGRQ), the Korean version of the COPD Assessment Test (K-CAT), and the Korean version of the EuroQoL-5 Dimensions (K-EQ-5D). To assess test-retest reliability, the K-LCADL was again administered to the same patients within 2 weeks from initial assessment. RESULTS: A total of 94 patients participated in the present study. The total K-LCADL score was positively correlated with the K-SGRQ (r=0.802, p < 0.001), the mMRC dyspnea scale (r=0.603, p < 0.001), and the K-CAT score (r=0.714, p < 0.001), and negatively correlated with the K-EQ-5D (r=−0.764, p < 0.001), 6MWT (r=−0.635, p < 0.001), forced expiratory volume in one second 1 (r=−0.416, p=0.002), and forced vital capacity (r=−0.397, p=0.023). Intraclass correlation coefficient of the K-LCADL was 0.951 (p < 0.001). CONCLUSION: The K-LCADL is a reliable and valid questionnaire for evaluating limitation of activities of daily living in patients with COPD.
